Invention Grant
- Patent Title: Compositions and methods comprising digital signatures to predict response and resistance to targeted therapy and immunotherapy
-
Application No.: US18047910Application Date: 2022-10-19
-
Publication No.: US12054787B2Publication Date: 2024-08-06
- Inventor: Xiaole Liu , Peng Jiang
- Applicant: DANA-FARBER CANCER INSTITUTE, INC.
- Applicant Address: US MA Boston
- Assignee: Dana-Farber Cancer Institute, Inc.
- Current Assignee: Dana-Farber Cancer Institute, Inc.
- Current Assignee Address: US MA Boston
- Agency: ArentFox Schiff, LLP
- Agent Daniel W. Clarke
- Main IPC: C12Q1/6886
- IPC: C12Q1/6886
Abstract:
The present invention relates to gene expression signatures that predict response and resistance to targeted therapy and immunotherapy.
Public/Granted literature
Information query
IPC分类:
